Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Testing type
6.1 Introduction
6.2 Newborn Screening
6.3 Carrier Testing
6.4 Predictive and Presymptomatic Testing
6.4.1 Cancer Panel
6.4.2 BCRA
6.5 Forensic Testing
6.6 Diagnostic Testing
6.6.1 Liquid Biopsy
6.7 Prenatal Testing
6.7.1 NIPT
Chapter 7 Market Segmentation by Methods
7.1 Introduction
7.2 Chromosomal Genetic Testing
7.3 Biochemical Genetic Testing
7.4 Molecular Genetic Testing
Chapter 8 Market Segmentation by Testing Sample
8.1 Introduction
8.2 Blood
8.3 Saliva
8.4 Tumours
8.5 Hair
Chapter 9 Market Segmentation by Industry
9.1 Laboratories
9.2 Blood Banks
9.3 Nursing Homes
9.4 Hospitals
9.5 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 India
10.1.4 Japan
10.1.5 Australia
10.1.6 Others
10.2 North America
10.2.1 Introduction
10.2.2 United States
10.2.3 Canada
10.2.4 Mexico
10.2.5 Others
10.3 Europe
10.3.1 Introduction
10.3.2 Spain
10.3.3 UK
10.3.4 France
10.3.5 Russia
10.3.6 Italy
10.3.7 Others
10.4 The Middle East and Africa
10.4.1 Introduction
10.4.2 South Africa
10.4.3 Middle East Countries
10.4.4 Others
10.5 South America
10.5.1 Introduction
10.5.2 Argentina
10.5.3 Brazil
10.5.5 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1 Analogic Corporation
12.1.1 Business Overview
12.1.2 Product portfolio
12.1.3 Key Strategy
12.1.4 Recent Developments
12.2 Ranomics
12.3 Applied Biosystems, Inc.
12.4 Biocartis SA
12.5 Daan Diagnostics Ltd
12.6 Celera Group
12.7 Genentech, Inc.
12.8 DNAFit
12.9Eastern Biotech
12.10Perkinelmer, Inc.
12.11Dna Consultants
12.12Qiagens N.V.
12.13Sorenson Genomics, LLC
12.14Myriad Genetics
12.15Transgenomic, Inc.
Chapter 13 Market Estimates and Forecast
13.1 Market Estimates and Forecast 2018-2024(USD Million)
13.1.1 Market Estimation and Forecast by Testing type 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecast by Methods 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecast by Testing Sample 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecast by Industry 2018-2024 (USD Million)
13.1.5 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
